Condensed Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions	Apr. 02, 2016	Dec. 31, 2015
Assets
Cash and cash equivalents	$ 588.9	$ 417.8
Accounts receivable, net of allowance for doubtful accounts of $4.3 million, and $4.5 million, respectively	1,188.0	1,189.0
Inventories	905.1	898.7
Prepaid expenses and other current assets	332.6	286.1
Total current assets	3,014.6	2,791.6
Property, plant and equipment, net	896.3	886.2
Tysabri® royalty stream - at fair value	5,020.0	5,310.0
Goodwill and other indefinite-lived intangible assets	6,873.6	7,069.0
Other intangible assets, net	3,374.8	2,973.1
Non-current deferred income taxes	86.8	71.4
Other non-current assets	233.6	248.3
Total non-current assets	16,485.1	16,558.0
Total assets	19,499.7	19,349.6
Liabilities and Shareholders’ Equity
Accounts payable	557.2	555.8
Payroll and related taxes	92.2	125.3
Accrued customer programs	316.7	396.0
Accrued liabilities	343.2	351.9
Accrued income taxes	262.4	62.7
Current indebtedness	650.7	1,060.5
Total current liabilities	2,222.4	2,552.2
Long-term debt, less current portion	5,902.7	4,971.6
Non-current deferred income taxes	1,240.7	1,372.7
Other non-current liabilities	408.5	346.3
Total non-current liabilities	7,551.9	6,690.6
Total liabilities	9,774.3	9,242.8
Commitments and contingencies - Note 14
Shareholders’ equity
Preferred shares, $0.0001 par value, 10 million shares authorized	0.0	0.0
Ordinary shares, €0.001 par value, 10 billion shares authorized	8,160.8	8,142.6
Accumulated other comprehensive income (loss)	137.4	(15.3)
Retained earnings	1,427.8	1,980.1
Total controlling interest	9,726.0	10,107.4
Noncontrolling interest	(0.6)	(0.6)
Total shareholders’ equity	9,725.4	10,106.8
Total liabilities and shareholders' equity	$ 19,499.7	$ 19,349.6
Supplemental Disclosures of Balance Sheet Information
Preferred shares, issued and outstanding (in shares)	0.0	0.0
Ordinary shares, issued and outstanding (in shares)	143.2	143.1